top of page
UP_2016_1076_095_edited.jpg

Christopher A. Alabi

Associate Professor 

Nancy and Peter Meinig Family Investigator in the Life Sciences

Robert Frederick Smith School of Chemical and Biomolecular Engineering

Field Member  of Chemistry and Chemical Biology 

Field Member of Biomedical Engineering 

Field Member  of Materials Science and Engineering 

Cornell University

AIMBE Fellow

  • LinkedIn
  • Twitter

My Story

My academic journey started with a Bachelor of Science in Chemistry from New York University and a Bachelor of Engineering in Chemical Engineering from Stevens Institute of Technology. My passion for materials chemistry led me to the California Institute of Technology, where I earned my PhD under the mentorship of Mark Davis. In 2009, I embarked on an NIH Postdoctoral fellowship at MIT, working with renowned scientists Robert Langer and Dan Anderson. This experience paved the way for my academic career, and in 2013, I joined Cornell University as an Assistant Professor in the School of Chemical and Biomolecular Engineering. My research explores the synthesis and properties of novel sequence-defined peptidomimetics, synthetic macromolecules and drug delivery systems. This work has been recognized with awards like the NSF CAREER Award and the PMSE Young Investigator Award. I'm honored to be part of the AIMBE College of Fellows and deeply committed to teaching, earning accolades such as the 2017 Tau Beta Pi Professor of the Year Award and the 2022 Richard F. Tucker Excellence in Teaching Award. At the Alabi lab, we aim to understand how macromolecules' composition and sequence affect their physicochemical and biochemical properties toward engineering biomaterials and biomolecular therapeutics.

Our Research Journey

2013

ALABI LAB ESTABLISHED

Alabi Lab @ Cornell is founded with a vision to transform drug delivery strategies using cutting-edge research and technology. Key article published on multiparametric evaluation of LNPs for siRNA delivery: doi: 10.1073/pnas.1306529110

2014

BREAKTHROUGH IN OLIGOTHIOETHERAMIDES

Significant progress is made in the development of new sequence defined oligothioetheramides (OligoTEAs) in a JACS paper titled: Sequence-defined polymers via orthogonal allyl acrylamide building blocks.

Contact

I'm always looking for new and exciting opportunities. Let's connect.

607-255-7889

bottom of page